title: Paroxetine use during pregnancy and the risk of cardiac defects.
authors.affiliation: University of Montreal and CHU Ste-Justine, Montreal, Quebec, Canada.
authors.forename: Anick
authors.initials: A
authors.lastname: Bérard
authors.affiliation: University of Montreal and CHU Ste-Justine, Montreal, Quebec, Canada.
authors.forename: Sonia
authors.initials: S
authors.lastname: Chaabane
authors.affiliation: University of Montreal and CHU Ste-Justine, Montreal, Quebec, Canada.
authors.forename: Flory T
authors.initials: FT
authors.lastname: Muanda
authors.affiliation: University of Montreal and CHU Ste-Justine, Montreal, Quebec, Canada.
authors.forename: Takoua
authors.initials: T
authors.lastname: Boukhris
authors.affiliation: University of Montreal and CHU Ste-Justine, Montreal, Quebec, Canada.
authors.forename: Jinping
authors.initials: J
authors.lastname: Zhao
mesh_terms: D000014:Abnormalities, Drug-Induced; D018687:Antidepressive Agents, Second-Generation; D005260:Female; D006330:Heart Defects, Congenital; D006801:Humans; D017374:Paroxetine; D011247:Pregnancy; D011248:Pregnancy Complications; D012306:Risk; D017367:Selective Serotonin Reuptake Inhibitors
chemical_list: D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors